Novartis: CEO Vas Narasimhan's pay package speaks out:
nzz.ch/wirtschaft/novartis-sprintet-ohne-sandoz-davon-ld.1776736
Story Details
| Last Updated | Jan 31 |
| Total Articles | 2 |
News on this topic
Pharmaceutical industry: Novartis has doubled CEO Narasimhan's compensation: The American received the equivalent of more than 17 million euros in 2023 ...
handelsblatt.com/unternehmen/industrie/pharmabranche-novartis-hat-verguetung-von-konzernchef-narasimhan-verdoppelt/100011818.html
More articles on this subject
Previous
Pharmaceutical industry: Novartis has doubled CEO Narasimhan's compensation: The American received the equivalent of more than 17 million euros in 2023 ...
handelsblatt.com/unternehmen/industrie/pharmabranche-novartis-hat-verguetung-von-konzernchef-narasimhan-verdoppelt/100011818.html
Novartis raises guidance after beating Q1 expectations: Swiss drugmaker Novartis raised its full-year guidance on wider use of psoriasis and arthritis drug ...
reuters.com/business/healthcare-pharmaceuticals/novartis-lifts-fy-guidance-after-q1-results-beat-expectations-2024-04-23/
Quick Glance: Positive Quarterly Results Lead to Guidance Increase at Novartis
- Novartis raises its annual guidance following a successful first quarter.
- Revenue increased by 10% to $11.83 billion, with adjusted operating income growing by 16% to $4.54 billion.
- CEO Vas Narasimhan is focusing more on drug development and has been active in mergers and acquisitions.
- Novartis has secured promising drugs, including an experimental prostate cancer drug from Arvinas and the company MorphoSys, which develops cancer treatments, for 2.7 billion euros.
Job cuts at Novartis and Roche: a blow for the research center: The Swiss pharmaceutical industry is facing a bloodletting. Due to reorganizations at Novartis ...
nzz.ch/wirtschaft/novartis-und-roche-kuendigen-hochqualifizierten-spezialisten-ld.1825752
Whatever happened to the world’s most expensive drug?: Zolgensma came to the market five years ago with a price tag of $2.1 million. What happened to it?
swissinfo.ch/eng/multinational-companies/whatever-happened-to-the-worlds-most-expensive-drug/75388576
Novartis wants to buy a German cancer drugmaker as it stops recruiting for its own trials
qz.com/norvartis-morphosys-deal-cancer-trials-pause-1851403095
Novartis begins tender offer for cancer-focused MorphoSys: Novartis said on Thursday it has launched a tender offer to acquire MorphoSys ...
reuters.com/business/healthcare-pharmaceuticals/novartis-begins-tender-offer-morphosys-2024-04-11/
Novartis to cut 680 jobs in product development: Novartis is to cut up to 680 jobs in its development organisation, which helps bring its drugs to market ...
reuters.com/business/world-at-work/novartis-cut-680-jobs-product-development-2024-04-09/
Pharmaceutical company announces job cuts - hundreds of employees in two countries affected
fr.de/wirtschaft/pharmakonzern-kuendigt-stellenabbau-an-hunderte-mitarbeiter-in-zwei-laendern-betroffen-zr-92997399.html
Research: More People Use Mental Health Benefits When They Hear That Colleagues Use Them Too
hbr.org/2024/04/research-more-people-use-mental-health-benefits-when-they-hear-that-colleagues-use-them-too
Turkey vs. Zolgensma: the battle over the world’s most expensive drug: Turkey and Novartis are in a stand-off over approval of Zolgensma - a $2 ...
swissinfo.ch/eng/multinational-companies/turkey-vs-novartis-the-battle-over-the-worlds-most-expensive-drug/76341423
Q1/2024 check-up: how the Swiss economy is faring - SWI swissinfo.ch: The highlights of the Swiss economy in the first three months of 2024 - here is our ...
swissinfo.ch/eng/workplace-switzerland/q1-2024-check-up-how-the-swiss-economy-is-faring/75764295
Biotech Stocks Heat Up, Driven By A Spate Of Billion-Dollar Deals: Biotech stocks heated Thursday as Novartis scooped up a licensing pact with Arvinas and Janux ...
investors.com/news/technology/biotech-stocks-arvinas-novartis-licensing-deal-janux-takeover-interest/
Inside Vasant 'Vas' Narasimhan's transformation of Novartis, and more
forbesindia.com/article/column/inside-vasant-vas-narasimhans-transformation-of-novartis-and-more/92547/1
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Novartis AG 2024 Q1 - Results - Earnings Call Presentation: The following slide deck was published by Novartis AG in conjunction with their 2024 Q1 earnings call ...
seekingalpha.com/article/4685255-novartis-ag-2024-q1-results-earnings-call-presentation
Paid articlePaid
USFDA gives nod to Novartis’ therapy for rare cancer among children: The study reported a safety profile consistent with the adult population studied in NETTER-1 ...
financialexpress.com/healthcare/pharma-healthcare/usfda-gives-nod-to-novartis-therapy-for-rare-cancer-among-children/3468162/
Do babies have autism because their mothers took a Novartis drug? - Zofinger Tagblatt
zofingertagblatt.ch/klage-in-den-usa-asthma-mittel-von-novartis-sollte-schwangeren-bei-vorzeitigen-wehen-helfen-doch-hat-es-bei-babys-autismus-ausgeloest/
Basel - Novartis is growing faster than expected: The Basel pharmaceutical giant recorded strong growth rates in the first quarter. After the positive start to ...
verlagshaus-jaumann.de/inhalt.basel-novartis-waechst-staerker-als-erwartet.5cdb3a4b-4856-40f7-9e63-ac2af98ebdb3.html
Novartis: Strong Start To The Year With Beat-And-Raise First Quarter Results: Beat-and-raise first quarter puts Novartis in a good position for shareholder value ...
seekingalpha.com/article/4685295-novartis-strong-start-beat-and-raise-first-quarter-results
Paid articlePaid Novartis’ Multiple Sclerosis drug is effective for up to six years, study reveals
financialexpress.com/healthcare/news-healthcare/novartis-multiple-sclerosis-drug-is-effective-for-up-to-six-years-study-reveals/3462290/
Novartis Looks To Get Back On Track With Q1 Earnings: Novartis' key drugs like Fabhalta and Cosentyx may drive short-term growth, offsetting potential losses ...
seekingalpha.com/article/4684711-novartis-looks-to-get-back-on-track-with-q1-earnings
Paid articlePaid Inside Novartis' Outsized Play In India - Forbes India: Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis ...
forbesindia.com/audio/audio/inside-novartis-outsized-play-in-india/92631
Novartis will start doing more fundamental research work in India: Vas Narasimhan
forbesindia.com/article/leadership/novartis-will-start-doing-more-fundamental-research-work-in-india-vas-narasimhan/92613/1
Novartis: Innovating For The World, From India - Forbes India: How Vasant 'Vas' Narasimhan is readying India to play a bigger role in its medicines ...
forbesindia.com/article/leadership/novartis-innovating-for-the-world-from-india/92575/1
Novartis enters into licensing deal for Arvinas’ cancer drug worth up to $1.01 billion
financialexpress.com/healthcare/pharma-healthcare/novartis-enters-into-licensing-deal-for-arvinas-cancer-drug-worth-up-to-1-01-billion/3454058/
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Novartis cuts 440 jobs in Switzerland - Zofinger Tagblatt: Novartis cuts 440 jobs in Switzerland
zofingertagblatt.ch/novartis/
Apontis Pharma: Strong deal with Novartis - Share with price jump: Apontis Pharma cooperates with Novartis, raises forecast for 2024, shares rise by 10%.
deraktionaer.de/artikel/aktien/apontis-pharma-starker-deal-mit-novartis-aktie-mit-kurssprung-20354498.html
US appeals court revives Regeneron's antitrust lawsuit against Novartis: A U.S. appeals court on Monday revived an antitrust lawsuit by Regeneron Pharmaceuticals ...
reuters.com/legal/us-appeals-court-revives-regenerons-antitrust-lawsuit-against-novartis-2024-03-18/
CEO pay: can Switzerland compete with the US?: Swiss CEOs are some of the best paid in Europe but compared to peers in the US, their salaries look modest.
swissinfo.ch/eng/multinational-companies/ceo-pay-can-switzerland-compete-with-the-us/73415382
AstraZenca is betting $2 billion on next-generation cancer treatments: AstraZeneca is acquiring Fusion Pharmaceuticals in a $2-billion deal
qz.com/astrazeneca-fusion-pharmaceuticals-2-billion-acquisitio-1851348307
Paid articlePaid
Novartis Seeks Malaria Patients in New Places as Climate Shifts: Malaria season should be over in Burkina Faso and Mali. This year, that’s not the case ...
bloomberg.com/news/articles/2024-04-04/novartis-seeks-malaria-patients-in-new-places-as-climate-shifts
Paid articlePaid
AHV vote: Now the top earners come to the checkout: Sergio Ermotti and Novartis boss Vas Narasimhan pay over a million francs annually into the AHV ...
tagesanzeiger.ch/ahv-abstimmung-jetzt-kommen-die-spitzenverdiener-an-die-kasse-692829873364
Paid articlePaid
Social enterprises: Good deeds should be countable: To the extent that politics legalizes sustainability, the charitable actions of corporations also change ...
faz.net/aktuell/wirtschaft/unternehmen/dax-konzerne-nachhaltigkeit-soll-zaehlbar-sein-19593345.html
Paid articlePaid Trend towards frosted facades: Architecture degenerates into a disco ball: The MSG Sphere in Las Vegas and the Novartis Pavilion in Basel reduce the façade to an ...
nzz.ch/feuilleton/trend-zu-mattscheiben-fassaden-architektur-verkommt-zur-discokugel-ld.1777408
3 Top Stocks to Watch From the Best International Money Managers: Managers of highly rated funds own these foreign stocks. Should you?
morningstar.com/stocks/3-top-stocks-watch-best-international-money-managers-2
Basel - Cartel Office says yes: The pharmaceutical company Novartis is allowed to take over the German company Morphosys.
verlagshaus-jaumann.de/inhalt.basel-kartellamt-sagt-ja.8c6a8759-0819-40ed-8d60-d175c844e136.html
Sandoz is doing well outside the Novartis group: Sandoz clearly returned to growth last year. Business was particularly good in the USA. At the same time ...
nzz.ch/wirtschaft/sandoz-geglueckter-start-in-die-selbstaendigkeit-dem-generikahersteller-geht-es-ohne-den-perfektionismus-von-novartis-besser-ld.1822046
Paid articlePaid Biotech: Morphosys writes deep red figures before takeover by Novartis: Group loss increased to just under 190 million euros in 2023 from a good 151 million a ...
handelsblatt.com/unternehmen/industrie/biotech-morphosys-schreibt-vor-uebernahme-durch-novartis-tiefrote-zahlen/100023761.html
Roche family shareholders need strong nerves: Roche bought back a large block of shares from Novartis in 2021. This increased the influence of family ...
nzz.ch/wirtschaft/roche-familienaktionaere-brauchen-starke-nerven-ld.1820959
Paid articlePaid In Memorium: Ranjit Shahani: Ranjit Shahani aged 73 passed away on March 9. Industry and well-wishers mourn his sad demise.
financialexpress.com/healthcare/in-memorium-ranjit-shahani/3420412/
Beyond the Magnificant Seven like NASDAQ's NVIDIA: These European stocks could be worthwhile for investors
finanzen.net/nachricht/aktien/diversifizierung-jenseits-von-nvidia-co-diese-europaeischen-aktien-koennten-sich-fuer-anleger-lohnen-13330156
FDA approves medication used to treat asthma for use in people with multiple food allergies
cnn.com/2024/02/16/health/fda-medication-to-help-multiple-food-allergies/
Paid articlePaid
Who was Ranjit Shahani: A titan in India's pharmaceutical, business landscape. Know his contributions and more | Mint
livemint.com/companies/people/who-was-ranjit-shahani-a-titan-in-indias-pharmaceutical-business-landscape-know-his-contributions-and-more-11709973943106.html
Former Vice Chairman of Novartis India Ranjit Shahani passes away | Mint: Ranjit Shahani, former Vice Chairman and Managing Director of Novartis India and ...
livemint.com/news/india/vice-chairman-novartis-india-ranjit-shahani-passes-away-jb-pharmaceuticals-news-death-11709972334774.html
Basel: Trade with Slovenia explodes, the pharmaceutical industry is behind it: Within just a few years, Slovenia has become one of the most important trading ...
bzbasel.ch/basel/basel-stadt/aussenhandel-novartis-co-gehen-fremd-oder-warum-basel-fuer-slowenien-ploetzlich-so-wichtig-ist-ld.2586028
Paid articlePaid SHAREHOLDER hot stock Eckert & Ziegler: The tension is rising: Eckert & Ziegler cooperates with Novartis in Japan and plans to spin off Pentixapharm.
deraktionaer.de/artikel/aktien/aktionaer-hot-stock-eckert-ziegler-die-spannung-steigt-20351608.html
Egypt’s Health Ministry, Novartis sign protocol to modernise cardiac catheterisation system - Dailynewsegypt
dailynewsegypt.com/2024/02/26/egypts-health-ministry-novartis-sign-protocol-to-modernise-cardiac-catheterisation-system/
Reduce the exits: Of late, however, there have been several instances of MNCs quitting India or scaling down their stake in their India subsidiaries.
financialexpress.com/opinion/reduce-the-exits/3403815/
UK's MHRA revokes authorisation for Novartis' sickle cell drug: Britain's health regulator said on Wednesday it had revoked a conditional marketing authorisation ...
reuters.com/business/healthcare-pharmaceuticals/uks-mhra-revokes-authorisation-novartis-sickle-cell-drug-2024-02-21/
Dr Reddy’s may join race to acquire Novartis’ India arm: The exclusive sales and distribution agreement includes medicines such as the Voveran range ...
financialexpress.com/business/industry-dr-reddys-may-join-race-to-acquire-novartis-india-arm-3397396/
Novartis soars 11%; board to support parent firm explore strategic options: According to reports, Dr Reddy's Laboratories is likely in a race to acquire Novartis ...
business-standard.com/markets/news/novartis-soars-11-board-to-support-parent-firm-explore-strategic-options-124021900364_1.html
Novartis announces strategic review of Novartis India Limited: Drug major Novartis AG on Friday announced a strategic review of Novartis India Ltd ...
business-standard.com/companies/news/drug-major-novartis-ag-announces-a-strategic-review-of-india-unit-124021601190_1.html
Plant expansion in Schaftenau and Kundl: Novartis creates 350 new jobs in Tyrol | Tyrolean daily newspaper online
tt.com/artikel/30876060/anlagen-ausbau-in-schaftenau-und-kundl-novartis-schafft-350-neue-jobs-in-tirol
Morphosys: Is the rise now coming before the exit?: Morphosys could soon be promoted to the MDAX, but is about to be taken over by Novartis.
deraktionaer.de/artikel/pharma-biotech/morphosys-kommt-jetzt-der-aufstieg-vor-dem-ausstieg-20350352.html
A price for progress: Who pays for genetic engineering?: Genetic engineering can be used to cure sick children and grow strong plants. Now we need to find the ...
faz.net/aktuell/wirtschaft/unternehmen/vielversprechende-erfolge-in-der-forschung-wer-zahlt-fuer-die-gentechnik-19509224.html
Paid articlePaid New medicine is needed: The pharmaceutical industry is looking for the next cash cow
faz.net/aktuell/wirtschaft/unternehmen/novartis-offerte-fuer-morphosys-die-pharmabranche-sucht-den-naechsten-goldesel-19500881.html
Paid articlePaid
Big Money invests here: Discover the top investments of the best portfolio managers and benefit from their expertise in the new €uro am Sonntag edition.
boerse-online.de/nachrichten/geld-und-vorsorge/hier-investiert-big-money-20350031.html
Tiny, entangled universes that form or fizzle out – a theory of the quantum multiverse | Aeon Videos
aeon.co/videos/tiny-entangled-universes-that-form-or-fizzle-out-a-theory-of-the-quantum-multiverse
Houghton hotel nightporter who got addicted to energy drinks stole from work to fund his 15-can-a-day habit
sunderlandecho.com/news/crime/houghton-hotel-nightporter-who-got-addicted-to-energy-drinks-stole-from-work-to-fund-his-15-can-a-day-habit-4607029
The 18 cheapest neighbourhoods to buy a home in Sunderland, including Hendon and Houghton
sunderlandecho.com/lifestyle/homes-and-gardens/the-18-cheapest-neighbourhoods-to-buy-a-home-in-sunderland-including-hendon-and-houghton-4603295
Paid articlePaid
Pioneer Ketchum: Paid parental leave for everyone: It may be unique in the agency industry: The PR agency Ketchum has decided to give its employees a special ...
wuv.de/Themen/Agentur/Vorreiter-Ketchum-Bezahlte-Elternzeit-fuer-alle
Paid articlePaid
Leader - For those in peril on the sea: None of us knows when we might be in need of the RNLI
scotsman.com/news/opinion/leader-for-those-in-peril-on-the-sea-4582321
'Are they real?' Couple who walk exotic birds through Oban say people can't believe their eyes
pressandjournal.co.uk/fp/news/highlands-islands/6427737/oban-parrot/
Harvard says it’s removed human skin from binding of 19th century book: Scientific analysis done in 2014 confirmed the binding was made of human skin
theglobeandmail.com/world/article-harvard-says-its-removed-human-skin-from-binding-of-19th-century-book/
Paid articlePaidQuick Glance: Harvard University Removes Human Skin Binding from Infamous Library Book
- Harvard University has removed the human skin binding from the infamous book 'Des Destinées de l’Ame,' housed in the Houghton Library of the university.
- The 19th-century text by Arsène Houssaye was bound using stolen skin from a deceased female medical patient.
- The university is working to research the patient's origins and collaborating with authorities to determine a respectful disposition of these human remains.
- Harvard apologized for past failures and emphasized the removal of the skin binding as part of recommendations from the Report of the Harvard University Steering Committee on Human Remains in University Museum Collections.
Appeal to trace family of Houghton man John Douglas: Mr Douglas is believed to have a brother.
sunderlandecho.com/news/appeal-to-trace-family-of-houghton-man-john-douglas-4579539
Paid articlePaid 11 ways you spent your Easter break in Sunderland over the years - a feast of eggs, bunnies and treasure hunts
sunderlandecho.com/retro/easter-sunderland-herrington-houghton-retro-4569630
Paid articlePaid Takeover speculation! Cytokinetics shares jump - does Eli Lilly strike?: Eli Lilly is rumored to be interested in acquiring Cytokinetics.
deraktionaer.de/artikel/pharma-biotech/uebernahmespekulationen-cytokinetics-aktie-springt-an-schlaegt-eli-lilly-zu-20353862.html
Postcode Lottery wins in Durham, Darlington, Houghton: A number of postcodes in the North East have won thousands of pounds in the postcode lottery over the last ...
thenorthernecho.co.uk/news/24205479.postcode-lottery-wins-durham-darlington-houghton/
Penicillin: Sandoz opens new antibiotic production facility in Kundl - Kufstein: Pharmaceutical company celebrated the opening of the new production facility in ...
meinbezirk.at/kufstein/c-wirtschaft/sandoz-eroeffnet-neue-antibiotika-produktionsanlage-in-kundl_a6595590
UK Risks Critical Medicine Shortage as EU Lures Drugmakers, Sandoz Says: Britain risks running out of critical medicines because it’s failing to stay competitive ...
bloomberg.com/news/articles/2024-03-22/uk-risks-critical-medicine-shortage-as-eu-lures-drugmakers
Paid articlePaid End of China euphoria: Sandoz and Lonza call for withdrawal: After years of euphoria, there is increasing disillusionment with China in business circles ...
nzz.ch/wirtschaft/ende-der-china-euphorie-sandoz-und-lonza-blasen-zum-rueckzug-ld.1821678
Paid articlePaid Seven-mile car carry raises thousands for Sunderland's St Benedict's Hospice: The team raised more than anticipated.
sunderlandecho.com/news/people/seven-mile-car-carry-raises-thousands-for-st-benedicts-hospice-4558804
Paid articlePaid Tenax Capital Pulls Back on Cat Bond Investing: A hedge fund that last year delivered its best result ever thanks to catastrophe bonds is now scaling back its ...
bloomberg.com/news/articles/2024-03-12/hedge-fund-that-rode-huge-cat-bond-rally-mounts-tactical-retreat
Paid articlePaid Four arrests after police find crowbar and balaclavas in car in Houghton: Four men have been arrested after police found crowbars, balaclavas and gloves when ...
sunderlandecho.com/news/crime/four-arrests-after-police-find-crowbar-and-balaclavas-in-car-4551875
Paid articlePaid Formycon: Next approval - this mark must now hold: Formycon receives approval for its Lucentis biosimilar in Saudi Arabia.
deraktionaer.de/artikel/pharma-biotech/formycon-naechste-zulassung-diese-marke-muss-jetzt-halten-20352550.html
15 locations in Washington and Houghton with the most crimes reported, according to latest figures
sunderlandecho.com/news/crime/15-locations-in-washington-and-houghton-with-the-most-crimes-reported-according-to-latest-figures-4544945
Paid articlePaid
Xolair a New Weapon Against Food Allergies, but Questions Remain: An old drug offers new tricks for people with multiple food allergies, but costs and access ...
webmd.com/allergies/news/20240304/xolair-a-new-weapon-for-food-allergies
A revaluation of teachers and schools is not off the cards: As the acrimonious cycle of pay dispute restarts, teachers should draw inspiration from the events of ...
schoolsweek.co.uk/historys-repetitions-offer-hope-over-pay-and-conditions/
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics